Brassinosteroids are plant natural products with structural similarities to animal steroid hormones. They are found throughout the plant kingdom, and when applied exogenously at nanomolar to micromolar levels in a number of test systems, they exhibit a wide spectrum of physiological effects, including a marked promotion of cell elongation [1] . Like animal steroid hormones, brassinosteroids regulate the expression of specific genes [2, 3] . Together, these facts suggest that brassinosteroids may serve as one of the critical signals controlling plant growth and development.
Those few laboratories that have consistently worked on brassinosteroids over the past decade have proposed that these compounds deserve recognition as a sixth class of plant hormones, equal in stature to the better known auxins, cytokinins, gibberellins, abscisic acid and ethylene [4] . However, the plant community at large has been very slow to recognize brassinosteroids as important growth regulators. This may have been because of a lack of unequivocal proof that brassinosteroids are essential for plant growth and development, despite the large body of physiological data gathered since the first publication of a brassinosteroid structure [5] . Furthermore, the molecular mechanism of brassinosteroid action is uncertain, although one might argue from structural considerations that they are likely to work by a mechanism similar to that of animal steroid hormones, which generally act via a soluble receptor-ligand complex that binds to nuclear sites to regulate the expression of specific genes [6] .
Mutants of Arabidopsis thaliana that are deficient in or insensitive to plant hormones have been used extensively in the study of abscisic acid, auxin, ethylene and gibberellin action over the past decade [7] . Hormonedeficient mutants usually result from lesions in genes encoding biosynthetic enzymes and are rescued to a wildtype phenotype by treatment with the hormone. This is generally considered to be strong evidence that the hormone in question is required for a normal phenotype.
Hormone-insensitive mutants may show the same phenotype as deficient mutants, but are not rescued by hormone treatment. Insensitive mutants usually result from lesions in genes encoding the hormone receptor or elements of the signal transduction pathway.
Numerous structure-function analyses have defined the specific requirements for brassinosteroid activity [1] . In order to transform a commonly occurring plant sterol such as campesterol into an active brassinosteroid, the cell must accomplish a series of reductions, oxidations and epimerizations. The complete biosynthetic pathway of the brassinosteroid brassinolide, via campesterol, has recently been defined by several groups in Japan [8] . With the brassinosteroid biosynthetic pathway now established ( Fig. 1) , it should be possible to identify mutants that affect ratecontrolling steps in the pathway, resulting in reduced brassinosteroid levels in the mutant plants. The phenotype of such mutants would provide a critical test of the importance of brassinosteroids in normal plant growth and development. For example, if brassinosteroids are required for cell elongation, brassinosteroid-deficient mutants would be expected to display a dwarf phenotype. A direct search for brassinosteroid biosynthetic mutants has not been undertaken, but the re-examination of Arabidopsis dwarf mutants, selected by mutant screens for defects in physiological processes thought to be independent of brassinosteroids, has uncovered a series of very exciting results.
When dicotyledonous plants, such as Arabidopsis, are grown in darkness they show an etiolated phenotype which includes an elongated hypocotyl, a pronounced apical hook, small folded cotyledons, undeveloped chloroplasts and repression of light-regulated gene expression. When such plants are grown in the light, hypocotyl elongation is inhibited, cotyledons open, primary leaves and mature chloroplasts develop and transcript levels of lightregulated genes increase dramatically. To study how light controls developmental pathways, a number of Arabidopsis mutants -known as det (de-etiolated) and cop (constitutive photomorphogenesis) mutants -have been identified that have characteristics of light-grown plants even when grown in complete darkness [9] . Loss-of-function mutations in the DET and COP genes lead to pleiotropic defects in development in both the dark and the light. One such mutant, det2, when grown in the light has an extremely dwarfed phenotype (as a result of reduced cell size), dark green leaves, reduced male fertility and apical dominance, delayed flowering and a delay of leaf and chloroplast senescence. Such a broad spectrum of effects shows that DET2 plays an important role in development throughout the Arabidopsis life cycle.
The DET2 gene has recently been cloned by chromosome walking, and sequence analysis revealed a surprising similarity to mammalian steroid 5␣-reductases, which catalyze the NADPH-dependent conversion of testosterone to dihydrotestosterone [10] . There is 38-42 % sequence identity between DET2 and the mammalian genes, and the sequence similarity increases to 54-60 % when conservative substitutions are taken into account. Even more convincing, 80 % of the conserved residues in the mammalian enzymes are found in the DET2 protein, including a glutamate that is absolutely required for mammalian enzyme activity. This glutamate is changed to a lysine in the det2-1 and det2-6 alleles, both of which have very severe effects in spite of being simple missense mutations. The first step in the brassinosteroid biosynthetic pathway is the reduction of campesterol to campestanol, which is strikingly similar to the conversion of testosterone to dihydrotestosterone by the mammalian 5␣-reductase. This suggests that DET2 catalyzes the conversion of campesterol to campestanol.
Direct proof that det2 is a brassinosteroid-deficient mutant came from feeding experiments [10] . Brassinolide rescued the det2 mutant phenotype to wild-type in a dose-dependent manner both in the light and the dark. In contrast, neither gibberellins nor auxin rescued the mutant phenotype. The observations that DET2 is required for brassinosteroid biosynthesis, and that loss-of-function mutations in DET2 lead to manifold alterations in developmental pathways, provide convincing genetic evidence that brassinosteroids are essential for normal plant growth. Besides contributing to cell elongation, a well-known brassinosteroid effect, it appears that brassinosteroid levels play a role in other etiolated developmental responses, as well as leaf development, apical dominance, flowering time, fertility and senescence in the light.
Further genetic evidence that brassinosteroids play an essential role in plant development comes from recent work at the Max Planck Institute. By screening an Arabidopsis mutant collection for plants defective in hypocotyl elongation in the dark, Szekeres et al. [11] identified a recessive mutation called cpd -for constitutive photomorphogenesis and dwarfism -with a phenotype similar to det2 (though cpd and det2 are not allelic). In the dark, the cpd mutant displayed the typical de-etiolated response, while in the light it was an extreme dwarf (20-30-fold smaller than wild type). The latter, dwarf phenotype included: dark green, rounded, downward-curling leaves, chloroplast development in roots, altered stomatal density, thick transverse files of cellulose microfibrils in hypocotyl epidermal cells, unequal division of the cambium producing extra phloem cells at the expense of xylem, and male sterility due to the inability of pollen to elongate.
The CPD gene was cloned and found to encode a protein with 50-90 % sequence identity to conserved domains of microsomal cytochrome P450 monooxygenases [11] . Furthermore, the sequence shows some similarity to the specific domains of steroid hydroxylases, including rat testosterone-16␣-hydroxylase (24 % identity) and human progesterone-21␣-hydroxylase (19 % identity). Therefore, it appears that the CPD gene encodes another enzyme in brassinosteroid biosynthesis, this time involving a hydroxylation step. When the cpd mutant was grown in the presence of C-23 hydroxylated brassinosteroid precursors (Fig. 1) -including teasterone, 3 -dehydroteasterone, typhasterol and castasterone -it was completely rescued to a wild-type phenotype in light or darkness. However, cathasterone and its precursors, which lack a hydroxyl at C-23, failed to rescue the cpd mutant, suggesting that the CPD protein acts in the hydroxylation of cathasterone to teasterone during brassinosteroid biosynthesis.
The overlapping phenotypes of det2 and cpd mutants provide confirmation of the role of brassinosteroids in the aspects of development outlined above. The altered microfibril orientation and xylem development in the cpd mutant confirms previous physiological studies that implicated brassinosteroids in these processes. An allele of cpd, called cabbage3 (cbb3), has been independently isolated [12] . A careful study of cbb3 responses to phytohormones and their antagonists showed that auxins, auxin antagonists, gibberellins, ethylene-releasing compounds, ethylene inhibitors, cytokinins and jasmonic acid could not rescue the cbb3 phenotype. Moreover, only active brassinosteroids, and not any other structurally related sterol, could rescue the cbb3 mutant phenotype to wild type [12] .
A brassinosteroid-insensitive Arabidopsis mutant, named bri1 (brassinosteroid-insensitive), has also been identified [13, 14] . This mutant has the same severely dwarfed phenotype, altered leaf morphology, reduced apical dominance and male sterility seen in the cpd and det2 mutants. The phenotype is caused by a single recessive allele with pleiotropic effects that profoundly influences growth and development. The hormone insensitivity is specific to brassinosteroids and the mutant phenotype is not rescued by brassinosteroid treatment. A second brassinosteroidinsensitive mutant, cbb2, has recently been isolated that has a very similar phenotype to bri1 [12] . Expression of brassinosteroid-regulated genes is absent in both brassinosteroidinsensitive and brassinosteroid-deficient mutants [12] . It is not surprising that both brassinosteroid-insensitive (bri1, cbb2) and brassinosteroid-deficient (det2, cpd) mutants show a similar dwarfed growth habit, as brassinosteroids have long been known to promote stem elongation. In both cases, it is likely that the lack of brassinosteroid action, either through reduced synthesis or reduced perception, causes a lack of cell elongation, perhaps through reduced expression of genes encoding the molecular components of the cell-elongation machinery.
The availability of at least two molecular markers for brassinosteroid biosynthesis -det2 and cpd -will allow elegant studies of the temporal and spatial regulation of brassinosteroid levels in response to developmental and environmental signals. For example, the role of DET2 as a negative regulator of de-etiolation must be expanded to a positive role in cell elongation, given its function as a brassinosteroid biosynthetic enzyme. Molecular probes for DET2 and CPD will allow precise studies of the role of light on brassinosteroid levels. Preliminary results on the effect of light, sugar and cytokinins on CPD expression have been reported [11] . Attempts are underway in two laboratories to clone the BRI1 and CBB2 loci. The dramatic and pleiotropic effects of these mutations suggest that BRI1 and CBB2 lie very early in the signal perception/transduction pathway. Therefore, cloning and characterization of BRI1 and CBB2 should lead to a major advance in our understanding of brassinosteroid action and help clarify whether plants and animals share similar mechanism of steroid-regulated gene expression.
The application of molecular genetics has brought brassinosteroids from the shadows to the full spotlight of plant hormone research. The availability of mutants and molecular probes, along with increased interest by several molecular laboratories, means that our understanding of these neglected regulators of plant growth and development should rapidly increase in the next few years.
